Health care attorney Rupa S. Lloyd, shareholder in GrayRobinson’s Gainesville and Jacksonville law firm offices, was appointed to serve on the Sid Martin Biotech’s newly revamped advisory board for the 2020 term. Sid Martin Biotech, a research center operated under the University of Florida’s UF Innovate, supports innovation at the University to move research discoveries from the laboratory to the market. In this advisory board role, Lloyd will utilize her two decades of experience in health law to aid Sid Martin Biotech clients.
Lloyd specializes in health care operational, corporate, transactional and regulatory matters. She advises clients in many facets of their business, including privacy and data security, fraud and abuse, corporate governance, labor relations, licensure and discipline, quality improvement and healthcare risk management. She routinely conducts due diligence including the preparation and negotiation of agreements in connection with telehealth, software licensing, EMR, practice sale and acquisition, medical equipment, real property leases, physician employment and medical directorships.
The four organizations that comprise UF Innovate – Tech Licensing, Ventures, the Hub and Sid Martin Biotech – form a comprehensive commercialization system that brings together five critical elements: facilities, capital management, talent, intellectual property, and technology-transfer expertise. Sid Martin Biotech nurtures startups with the resources and expertise they need to thrive, thereby creating jobs and economic prosperity. Learn more about UF Innovate here.
GrayRobinson is a full-service law and lobbying firm with attorneys and government relations professionals throughout 15 offices. The company’s attorneys, consultants, and regulatory professionals provide legal and government relations services to Fortune 500 companies, emerging businesses, lending institutions, local and state governments, developers, entrepreneurs, and individuals.
